Masimo (MASI) Income from Continuing Operations (2009 - 2026)
Masimo's (MASI) quarterly Income from Continuing Operations came in at 56300000.0 in Q2 2026, up 19.28% year-on-year from 47200000.0 in Q2 2025, and down 9.05% quarter-over-quarter from 61900000.0 in Q1 2026.
Masimo (MASI) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Masimo's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 56300000.0 for Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 19.28% year-over-year to 56300000.0 in Q2 2026; TTM through Apr 2026 was 216800000.0, a 592.65% increase from a year earlier, with the FY2026 full-year figure at 207700000.0, up 1182.1% from the prior year.
- Income from Continuing Operations retreated to 56300000.0 in Q2 2026 per MASI's latest filing, from 61900000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 61900000.0 in Q1 2026 and bottomed at 65000000.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 39400000.0 (2022), against an average of 32853722.22.
- Across the five-year window, Income from Continuing Operations plunged 208.15% in 2024 and jumped 195.23% in 2026, its largest moves.
- Year by year, Income from Continuing Operations stood at 40900000.0 in 2022, then soared by 46.94% to 60100000.0 in 2023, then plunged by 208.15% to 65000000.0 in 2024, then soared by 182.62% to 53700000.0 in 2025, then gained by 4.84% to 56300000.0 in 2026.
- Per Business Quant, the three latest MASI Income from Continuing Operations figures stand at 56300000.0 (Q2 2026), 61900000.0 (Q1 2026), and 53700000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 56.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 56.30 Mn |
| Jan 3, 2026 | 61.90 Mn |
| Sep 27, 2025 | 53.70 Mn |
| Jun 28, 2025 | 44.90 Mn |
| Mar 29, 2025 | 47.20 Mn |
| Dec 28, 2024 | -65.00 Mn |
| Sep 28, 2024 | 24.30 Mn |
| Jun 29, 2024 | 24.80 Mn |
| Mar 30, 2024 | 32.10 Mn |
| Dec 30, 2023 | 60.10 Mn |
| Sep 30, 2023 | 10.60 Mn |
| Jul 1, 2023 | 15.70 Mn |
| Apr 1, 2023 | 21.30 Mn |
| Dec 31, 2022 | 40.90 Mn |
| Oct 1, 2022 | 37.90 Mn |
| Jul 2, 2022 | 18.10 Mn |
| Apr 2, 2022 | 46.60 Mn |
| Jan 1, 2022 | 59.97 Mn |
| Oct 2, 2021 | 57.80 Mn |
| Jul 3, 2021 | 50.20 Mn |